A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Winnie Yeo Hye Jin Choi Jung-Hwan Yoon Ronnie T P Poon |
| Publication date | October 7, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |